SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 10-QSB

            QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE

                         SECURITIES EXCHANGE ACT OF 1934

                  FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2004

                            Commission File #2-89616

                      CONSOLIDATED MEDICAL MANAGEMENT, INC.

             (Exact name of registrant as specified in its charter)

                                     MONTANA
         (State or other jurisdiction of incorporation or organization)

                                   82-0369233
                      (IRS Employer Identification Number)

               11919 Sunray Avenue, Suite B, Baton Rouge, LA 70816
               (Address of principal executive offices)(Zip Code)

                                  225-292-5139
                (Registrant's telephone no., including area code)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding  12  months  (or  for such shorter period that the registrant was
required  to  file  such  reports),  and  (2)  has  been  subject to such filing
requirements  for  the  past  90  days.
Yes  [X]  No  [  ]

The  number  of shares outstanding of the Company's common stock as of March 31,
2004  is  shown  below:

Title  of  Class  Number of Shares Outstanding Common Stock, par value $.001 per
share  44,264,285

Documents  Incorporated  by  Reference:  None


<PAGE>
                      CONSOLIDATED MEDICAL MANAGEMENT, INC.

                                   FORM 10-QSB


                                Table of Contents

PART I - FINANCIAL INFORMATION

Item 1 - Financial Information

Item 2 - Management's Discussion and Analysis of Financial Condition or Plan of
Operations

Item 3 - Controls and Procedures


PART II - OTHER INFORMATION

Item 2 - Changes in Securities and Use of Proceeds

Item 6 - Exhibits and Reports on Form 8-K

SIGNATURES


<PAGE>
                         PART I - FINANCIAL INFORMATION

ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS

The financial statements of the company are set forth beginning on page F-1.

                         PART I - FINANCIAL INFORMATION
                         ------------------------------

ITEM 1. FINANCIAL STATEMENTS
AS USED HEREIN, THE TERM "COMPANY" REFERS TO CONSOLIDATED MEDICAL MANAGEMENT
INC. UNLESS OTHERWISE INDICATED. CONSOLIDATED UNAUDITED INTERIM FINANCIAL
STATEMENTS INCLUDING A BALANCE SHEET FOR THE COMPANY AS OF THE QUARTER ENDED
MARCH 31, 2004, STATEMENT OF OPERATIONS, AND STATEMENT OF CASH FLOWS FOR THE
INTERIM PERIOD UP TO THE DATE OF SUCH BALANCE SHEET AND THE COMPARABLE PERIOD OF
THE PRECEDING YEAR ARE ATTACHED AS PAGES 3 THROUGH 5 AND ARE INCORPORATED HEREIN
BY THIS REFERENCE.

                 [THIS SPACE HAS BEEN LEFT BLANK INTENTIONALLY]


                                       F-2
<PAGE>
<TABLE>
<CAPTION>
                     CONSOLIDATED MINERALS MANAGEMENT, INC.
                            (A MONTANA CORPORATION)
                           CONSOLIDATED BALANCE SHEET
                                  (UNAUDITED)

                                     ASSETS
                                     ------

                                                                          MARCH 31, 2004      DECEMBER 31, 2003
                                                                         ----------------    -------------------
<S>                                                                     <C>                 <C>
Current Assets
--------------
  Cash                                                                  $             739   $             13,659
                                                                         ----------------    -------------------
      Total Current Assets                                                            739                 13,659

Oil & Gas Properties - Non Producing                                               60,000                 60,000
Notes Receivable                                                                2,786,000              2,786,000
Investment in Intercontinental Fuel, LLC                                        1,320,000              1,320,000
                                                                         ----------------    -------------------
      Total Assets                                                      $       4,166,739   $          4,179,659
                                                                         ================   ===================

                 LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
                 ----------------------------------------------

Current Liabilities
-------------------
  Notes Payable-Current Portion                                         $          80,493   $             80,493
  Accounts Payable                                                                161,132                109,132
  Accrued Expenses                                                                359,481                339,157
  Convertible Debentures                                                          465,000                465,000
    and Notes Payable-Current Portion
  Other debentures & notes payable                                                500,000                500,000
                                                                         ----------------    -------------------
      Total Current Liabilities                                                 1,566,106              1,493,782


  Notes Payable - Long Term Portion                                                     0                      0
  Debenture Payable - Dr. Zehr                                                  2,000,000              2,000,000
  Note Payable - Dr. Zehr                                                         600,000                600,000
                                                                         ----------------    -------------------
      Total Long-Term Liabilities                                               2,600,000              2,600,000

      Total Liabilities                                                 $       4,166,106   $          4,093,782

Commitments and Contingencies:                                                                                 -
------------------------------

Stockholders' Equity
--------------------
  Preferred Stock
    20,000,000 authorized shares, par value $.001                       $               -   $                  -
    no shares issued and outstanding

  Common Stock
  $0.001 par value, 50,000,000 shares authorized 44,264,285
  shares issued and outstanding as of March 31, 2004 and                           44,273                 44,173
  35,618,486 shares issued and outstanding as of December
  31, 2003.


  Additional Paid-in-Capital                                                    4,052,505              4,047,605
  Retained Earnings (Deficit)                                                  (4,096,145)            (4,005,901)
                                                                         ----------------    -------------------

      Total Stockholders' Equity (Deficit)                                            633                 85,877
                                                                         ----------------    -------------------

      Total Liabilities and Stockholders' Equity (Deficit)              $       4,166,739   $          4,179,659
                                                                         ================   ===================
</TABLE>


                                       F-3
<PAGE>
<TABLE>
<CAPTION>
                      CONSOLIDATED MEDICAL MANAGEMENT, INC.
                            (A MONTANA CORPORATION)
                      CONSOLIDATED STATEMENT OF OPERATIONS
                                  (UNAUDITED)

                                                      THREE MONTHS ENDED MARCH 31,
                                                   ---------------------------------
                                                        2004              2003
                                                   --------------   -----------------
<S>                                                <C>              <C>
Revenues                                           $            -   $              -
--------

Operating Expenses
  Personnel Costs                                          19,000             19,000
  Consulting                                               41,084              7,950
  Legal and Professional                                    1,150              5,690
  Other Expenses                                            8,686              3,471
                                                   --------------   -----------------

  Total Operating Expenses                         $       69,920   $         36,111

Income (Loss) from Operations                             (69,920)           (36,111)

Other Income (Expenses)
  Interest Expense                                        (20,342)           (11,625)

                                                          (20,342)           (11,625)

Income (Loss) before Income Taxes                  $      (90,262)  $        (47,736)

Income Tax Expense                                              -                  -
                                                   --------------   -----------------

Net Income (Loss)                                  $      (90,262)  $        (47,736)
                                                   ===============  =================
Net Income (Loss) per Share                        $      (0.002 )  $          0.012
                                                   ===============  =================
</TABLE>


                                       F-4
<PAGE>
<TABLE>
<CAPTION>
                      CONSOLIDATED MEDICAL MANAGEMENT, INC.
                            (A MONTANA CORPORATION)
                      CONSOLIDATED STATEMENT OF CASH FLOWS
                                  (UNAUDITED)

                                                                             THREE MONTHS ENDED MARCH 31,
                                                                              2004                 2003
                                                                       -------------------  -------------------
<S>                                                                    <C>                  <C>
Cash Flows from Operating Activities:
------------------------------------
  Net Income (Loss)                                                    $          (90,262)  $         (220,386)
  Adjustments to Reconcile Net Income (Loss) to Net Cash Provided by
    Operating Activities:
      Depreciation and Amortization                                                     -                    -
      Non Cash Consulting and Services Paid by Stock Issue                              -              146,000
      (Increase) Decrease in Receivables                                                -              (23,952)
      (Decrease) Increase in Accounts Payable                                      52,000                5,012
      (Increase) Decrease in Interest Payable                                                           11,625
      (Decrease) Increase in Accrued Expenses                                      20,342                    -
                                                                       -------------------  -------------------
           Net Cash Provided (Used) by Operating Activities            $          (17,920)  $          (81,701)
                                                                       -------------------  -------------------

Cash Flows from Investing Activities:
------------------------------------
                                                                                        0
  Note Receivable - Collections                                                         -               55,453
  Oil & Gas Properties - Non Producing                                                                       -
                                                                       -------------------  -------------------

           Net Cash Provided (Used) by Investing Activities            $                    $           55,453
                                                                       -------------------  -------------------

Cash Flows from Financing Activities:
------------------------------------

  Proceed from Notes Payable                                                            -                7,600
  Common Stock                                                                      5,000               17,011
                                                                       -------------------  -------------------

           Net Cash Provided (Used) by Financing Activities            $            5,000   $           24,611
                                                                       -------------------  -------------------

Net Increase (Decrease) in Cash                                        $          (12,920)  $           (1,637)

Cash, Beginning of period                                                          13,659                5,470
                                                                       -------------------  -------------------

Cash, End of period                                                    $              739   $            3,833

Supplemental Disclosure of Cash Flow Information                       $                -                    -
  Cash Paid During the Period for:                                     $                -                    -
    Interest                                                           $                -   $                -
                                                                       ===================  ===================
    Income Taxes                                                       $                -   $                -
                                                                       ===================  ===================

Supplemental Disclosure of Non-Cash Financing Information:
  In the quarter ended March 31, 2004 and 2003,
    Non Cash Consulting and Services Paid by Stock Issue               $            5,000   $          146,000
</TABLE>


                                       F-5
<PAGE>
                          Notes to Financial Statements

NOTE 1 - BASIS OF PRESENTATION
------------------------------

GENERAL
-------
The  consolidated  unaudited  interim  financial statements of the Company as of
March  31,  2004  and for the three months ended March 31, 2004, included herein
have  been prepared in accordance with the instructions for Form 10QSB under the
Securities  Exchange  Act  of 1934, as amended, and Article 10 of Regulation S-X
under the Securities Act of 1933, as amended. The December 31, 2003 Consolidated
Balance  Sheet  was  derived  from  audited  financial  statements, but does not
include  all  disclosures  required by generally accepted accounting principles.
Certain  information  and  note  disclosures  normally  included  in  financial
statements  prepared in accordance with generally accepted accounting principles
have  been  condensed or omitted pursuant to such rules and regulations relating
to  interim  consolidated  financial  statements.

In  the  opinion  of management, the accompanying consolidated unaudited interim
financial  statements  reflect  all  adjustments,  consisting  only  of  normal
recurring adjustments, necessary to present fairly the financial position of the
Company  at  March  31,  2004, and the results of their operations for the three
months  ended March 31, 2004 and 2003, and their cash flows for the three months
ended  March  31,  2004  and  2003.

The  results  of  operations  for such periods are not necessarily indicative of
results  expected  for  the  full year or for any future period. These financial
statements should be read in conjunction with the audited consolidated financial
statements  as  of December 31, 2003 and related notes included in the Company's
Form  10-KSB  filed  with  the  Securities  and  Exchange  Commission

                                  ORGANIZATION
The  Company  was  incorporated under the laws of the State of Montana on August
13,  1981  under  the name Golden Maple Mining and Leaching Company, Inc. On May
23,  1998, the Company changed its name to Consolidated Medical Management, Inc.
In August 201, the Company decided to refocus on the oil and gas industry and is
currently  doing  business  as  Consolidated  Minerals  Management,  Inc.  CMMI
relocated  its  offices to 11919 Sunray Avenue Suite B, Baton Rouge, LA 70816 in
July  of  2003.

In  2003,  the  Company  acquired  a  5%  working  interest  in  PAR  Minerals
Corporation's Snake Bite Prospect (Richardson #1) in Edwards County, Texas.  The
purchase  price  of  CMMI's  interest in this prospect was $65,322.80.  CMMI has
partnered  with  PAR in an Ellenberger horizontal test.  The Richardson well was
sold  in  April  2003  for  $100,000.  In September 2003, CMMI purchased a 2.25%
working  interest  in  the  Snake  Bite  Ellenberger Prospect in Edwards County,
Texas, from North American Reserve Corp. for $60,000.  Acreage costs was $10,000
and  the  turnkey  drilling  cost for the Four Square Ranch #2 well was $50,000.
The  agreements calls for CMMI to pay $10,000 acreage cost for each well drilled
and  2.5%  of  the  drilling  cost for each well.  After CMMI participates in an
additional  seven  wells, CMMI becomes vested in the approximately 12,642 acres.
As  of  November  19, 2003, the Four Square #2 was producing 750 MCFD with 10-20
BWPD.  On  October 25, 2003, CMMI entered into a Farm In agreement with Dominion
III  for the purpose of providing CMMI's drilling cost for 3 additional wells in
the  Rolston  #1,  Four  Square Ranch #9  and Four Square Ranch #10 on the Snake
Bite  Prospect.  Dominion provided up to $150,000 and holds all the right, title
and  interest in these 3 wells and will receive 100% of the net revenue from the
Four Square Ranch #2 well until Dominion receives 125% of their cash outlay.  As
additional  consideration, CMMI issued 100,000 shares of restricted 144 stock to
Dominion  III.  CMMI  will back in for 65% if payout occurs after June 30, 2005.
As  of  December 1, 2003, the Four Square Ranch #9 was producing 4400MCFD with 6
BWPD  while the Rolston #1 was plugged and abandoned.  On January 26, 2004, CMMI
amended  the agreement to include two additional wells, Four Square Ranch #3 and
Hunt #1, for a cost of up to $210,000. All other terms and conditions remain the
same.  Current  plans  are  to  try and acquire additional drilling sites in the
immediate  area.

CMMI  acquired a fuel terminal facility in July 2003, located in Houston, Texas.
On  September  5,  2003,  CMMI  transferred  its  investment in this facility to
Intercontinental  Fuels,  LLC  (IFL).  CMMI  had  accumulated  costs  totaling
$2,750,000 in acquiring these assets.  In exchange for a 75% membership interest
in  IFL,  CMMI  transferred  certain  assets totaling $1,650,000.  The remaining
assets  were  transferred  in  exchange for a note receivable of $1,100,000.  On
September  15,  2003,  CMMI  entered into an option agreement with a third party
investor  for  two $100,000 notes.  The option, if exercised, is to purchase 800
units  of  IFL  for $8,000.  The option expires September 15, 2004.  CMMI repaid
the two notes on November 6, 2003.  On November 6, 2003, CMMI sold 1200 units of
IFL  for  $1,500,000 to a private investor.  The investor paid $750,000 cash for
600  units  and  signed  a note for an additional 600 units.  The 600 units paid
for with the note is being held in trust with CMMI's general counsel.  IFL has a
single  customer  who  has  contracted  with  the facility to purchase fuel on a
monthly  take  or  pay  basis.  CMMI loaned $550,000 at 6% to IFL on November 7,
2003  for  facility  maintenance  and  repayment  of  debt.


                                       F-6
<PAGE>
                          Notes to Financial Statements

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
---------------------------------------------------

ACCOUNTING  METHOD
------------------
Accounting  policies of the Company conform to the generally accepted accounting
principles  and  reflect  practices  appropriate  to  the  industry  in which it
operates.  The  significant  policies  are  summarized  below.

CASH FLOWS AND CONCENTRATION OF CREDIT RISK

Cash  consists  principally  of  demand  deposits  at  commercial  banks.  These
balances, as reflected in the bank's records, are insured by the Federal Deposit
Insurance  Corporation  up to $100,000. At December 31, 2003 and March 31, 2004,
the  Company's  deposits  did  not  exceed  the  insured  limits.

EARNINGS PER COMMON SHARE
-------------------------
The Company adopted Financial Accounting Standards (SFAS) No. 128, "Earnings Per
Share,"  which  simplifies  the  computation of earnings per share requiring the
restatement  of  all  prior  periods.

Basic  earnings  per  share  are  computed  on the basis of the weighted average
number  of  common  shares  outstanding  during  each  year.

Diluted  earnings  per  share  are computed on the basis of the weighted average
number of common shares and dilutive securities outstanding. Dilutive securities
having  an  anti-dilutive effect on diluted earnings per share are excluded from
the  calculation.  The Company does not have any dilutive securities as of March
31,  2004.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

The  preparation  of  financial statements requires management to make estimates
and assumptions that affect reported earnings. The estimates and assumptions are
evaluated  on  an  on-going  basis and are based on historical experience and on
other factors that management believes are reasonable. Estimates and assumptions
include,  but  are  not  limited  to  commitments  and  contingencies.

The  Company believes that the following represent the areas where more critical
estimates  and  assumptions  are  used  in  the  preparation  of  the  financial
statements:

LONG-LIVED  ASSET IMPAIRMENTS: The Company records impairments when the carrying
amounts of long-lived assets are determined not to be recoverable. Impairment is
assessed  and  measured  by  an estimate of future cash flows expected to result
from  the  use  of  the  asset  and  its eventual disposition. Changes in market
conditions  can  impact estimated future cash flows from use of these assets and
impairments  charges  may  be  required  should  such  changes  occur.

NOTE 3 - CONVERTIBLE DEBENTURES AND NOTES PAYABLE
-------------------------------------------------

The  Company issued convertible debentures in 1998 that are subordinated to bank
debt  and secured leases. The debentures are otherwise unsecured but are given a
preference over unsecured debt. The debentures include interest at fifteen (15%)
percent,  interest  is  payable  in  monthly  installments. Each debenture has a
conversion right for each holder to convert the debenture principal to shares of
the  Company's  common  stock  at the greater of $2.50 per share or ninety (90%)
percent  of  the  bid  price,  whichever  is  greater on the date of conversion.
Accrued  interest and any principal amount not converted to shares of stock will
be  paid  in  cash  at  conversion. The debentures are due one year from date of
issue.  All  debentures issued in 1998 were due in 1999, and they are in default
as  of  March  31,  2004.

The  Company  issued convertible promissory notes payable in 1998. The notes are
unsecured  and  include  interest  at  ten (10%) percent, interest is payable in
monthly  installments.  Each  note  has  a  conversion  right for each holder to
convert  the  note's  unpaid  principal  to shares of the Company's common stock
based  on $2.50 per share, or a total of 90,000 at the note holder's discretion.
Accrued  interest and any principal amount not converted to shares of stock will
be  paid  in  cash  at conversion. As of December 31, the company had issued and
outstanding  $325,000  in debentures. The notes were due July 31, 1999, and they
are  in  default  as  of  March  31  2004.


                                       F-7
<PAGE>
                          Notes to Financial Statements

NOTE 3 - CONVERTIBLE DEBENTURES AND NOTES PAYABLE (CON'T)
---------------------------------------------------------

The  Company  has  entered  into  an  agreement  with  Spectrum  Financial, Inc.
("Spectrum")  whereby  Spectrum  will exchange shares it owns with the debenture
holder  upon  exercise  of the debenture's conversion option, in satisfaction of
the Company's obligations under the conversion provisions. In exchange, Spectrum
will  then  receive  an  unsecured  note  payable from the Company  for the face
amount  of  the  debenture surrendered. During the year ended December 31, 1998,
Spectrum  exchanged  a  total  of  14,000  of its shares in connection with this
agreement  and  received  five  notes payable from the Company totaling $35,000.


     Total  Convertible  Debentures  and  Notes  Payable    $       465,000
     Less:  Current  Portion                                       (465,000)
                                                            ----------------
     Long-Term  Portion                                     $            -0
                                                            ================

The Company issued Debenture No 299 in the amount of $350,000 on April 15, 2003.
The  Debenture bears interest at the rate of 5% per annum and matures on October
15,  2003.  The  debenture  is  in  default.

The Company issued Convertible Debenture No 300 on April 15, 2003. The debenture
bears  interest  at  the rate of 5% per annum and matures on April 15, 2006. The
debenture is convertible after April 15, 2004 into $2,000,000 of common stock at
a  cost per share of seventy per cent of the average bid price for the stock for
the  immediate  twenty  (20)  days  before  exercise.


NOTE 4 - COMMON AND PREFERRED STOCK
-----------------------------------

COMMON STOCK
------------

The  Company's  common  stock  is  $0.001 par value, there are 50,000,000 shares
authorized  as  of  as  of December 31, 2003 and March 31, 2004, the Company had
35,618,486  and  44,264,285  shares  issued  and  outstanding,  respectively.

PREFERRED STOCK
---------------

In  1998,  the  Company amended its articles to authorize Preferred Stock. There
are  20,000,000  shares  authorized  with a par value of $ 0.001. The shares are
non-voting and non-redeemable by the Company. The Company further designated two
series  of  its  Preferred  Stock:  "Series  'A'  $12.50  Preferred  Stock" with
2,159,193  shares of the total shares authorized and "Series 'A' $8.00 Preferred
Stock,"  with  the  number  of  authorized shares set at 1,079,957 shares. As of
March 31, 2004 and December 31, 2003 there are no shares issued and outstanding.

DIVIDENDS
---------

Dividends are non-cumulative, however, the holders of such series, in preference
to  the  holders  of any common stock, shall be entitled to receive, as and when
declared  payable by the Board of Directors from funds legally available for the
payment  thereof,  dividends  in lawful money of the United States of America at
the  rate  per annum fixed and determined as herein authorized for the shares of
such  series,  but  no  more, payable quarterly on the last days of March, June,
September, and December in each year with respect to the quarterly period ending
on  the  day  prior  to  each such respective dividend payment date. In no event
shall  the  holders of either series receive dividends of more than percent (1%)
in  any  fiscal  year.  Each share of both series shall rank on parity with each
other  share  of  preferred  stock,  irrespective  of  series,  with  respect to
dividends  at  the  respective  fixed  or  maximum  rates  for  such  series.


                                       F-8
<PAGE>
                          Notes to Financial Statements

CONVERSION PROVISIONS
---------------------

Any holder of either series may convert any or all of such shares into shares of
common  stock  of the Company at any time. Said shares shall be convertible at a
rate  equal  to three (3) shares of common stock of the Company for each one (1)
share  of Series "A" of $ 12.50 Preferred Stock. The Series "A" $12.50 Preferred
Stock  shall  be  convertible, in whole or in part, at any time after the common
stock  of  the Company shall maintain an average bid price per share of at least
$12.50  for  ten  (10)  consecutive  trading  days.

Series  "A"  $8.00 Preferred Stock shall be convertible at a rate equal to three
(3)  shares  of common stock of the Company for each one (1) share of Series "A"
$8.00  Preferred  Stock.  The  Series  "A"  $8.00  Preferred  Stock  shall  be
convertible,  in  whole  or  in  part, at any time after the common stock of the
Company  shall maintain an average bid price per share of at least $8.00 for ten
(10)  consecutive  trading  days.

The  preferential  amount  payable  with  respect  to shares of either Series of
Preferred  Stock  in  the  event  of  voluntary  or  involuntary  liquidation,
dissolution,  or  winding-up,  shall be an amount equal to $5.00 per share, plus
the  amount  of  any  dividends  declared  and  unpaid  thereon.

NOTE 5 - COMMITMENT AND CONTINGENCIES

The  Company  has  not recognized any commitments or contingencies at this time.

The  Company's  financial  statements  are  prepared  using  generally  accepted
accounting  principles  applicable  to  a  going concern, which contemplates the
realization  of  assets  and  liquidation of liabilities in the normal course of
business.  However, the Company does not have significant cash, nor does it have
an  established  source  of  revenues  sufficient  to  cover its operating costs
raising  substantial  doubt  about  its  ability to continue as a going concern.


                                       F-9
<PAGE>
ITEM  2.  MANAGEMENT  DISCUSSION  AND ANALYSIS OF FINANCIAL CONDITION OR PLAN OF
OPERATIONS.

The  following  discussion  should  be  read  in  conjunction with our unaudited
consolidated  interim financial statements and related notes thereto included in
this  quarterly  report and in our audited consolidated financial statements and
Management's  Discussion  and  Analysis  of  Financial  Condition and Results of
Operations ("MD&A") contained in our Form 10-KSB for the year ended December 31,
2003.  Certain  statements in the following MD&A are forward looking statements.
Words  such as "expects", "anticipates", "estimates" and similar expressions are
intended  to identify forward looking statements. Such statements are subject to
risks  and  uncertainties  that  could cause actual results to differ materially
from  those  projected.

GENERAL

Consolidated  Medical Management, Inc. ("CMMI"), was incorporated under the laws
of  the  State  of Montana on August 13, 1981 under the name Golden Maple Mining
and  Leaching Company, Inc. On May 23, 1998, we changed our name to Consolidated
Medical  Management,  Inc. In August 2001, the Company decided to refocus on the
oil  and  gas industry and are currently doing business as Consolidated Minerals
Management,  Inc.  CMMI's address was 5161 San Felipe, Suite 320, Houston, Texas
77056  until  June 2003 when the company moved offices to 7500 San Felipe, Suite
600, Houston, Texas 77063.   In July 2003 the Company moved its offices to 11919
Sunray  Avenue,  Suite  B,  Baton  Rouge,  LA  70816.

RESULTS OF OPERATIONS

For  the quarter ended March 31, 2004, CMMI incurred a net loss of $90,262.  The
loss  in  entirely  attributable to accrual of expenses incurred for consultants
and  interest  on  debt.

The  Company  acquired a 5% working interest in PAR Minerals Corporation's Snake
Bite  Prospect (Richardson #1) in Edwards County, Texas. CMMI has partnered with
PAR  in  an Ellenberger horizontal test. The well began generating revenue sales
on  March  16,  2003.  (See comments in the Organization section)  Current plans
are  to  try  and  acquire  additional  drill  sites  in  the  immediate  area.


COMPARISON OF QUARTER ENDED MARCH 31, 2004 TO THE QUARTER ENDED MARCH 31, 2003

For  the  quarter ended March 31, 2004, our net loss was $ 90,262 as compared to
$47,736  for  the  quarter  ended  March 31, 2003. The increase is related to an
increase  in  consulting  fees  incurred  in  the  normal  course  of  business.

Total  Operating  Expenses  increased  from $36,111 in the first quarter 2003 to
$69,920  in  2004,  as  CMMI  accrued  payments due to consultants that provided
services  in  the  normal  course  of  business.

LIQUIDITY AND CAPITAL RESOURCES

Currently,  the  liabilities  shown  on  the  balance  sheet  are  current trade
payables,  and  accrued  expenses  and convertible debenture expenses related to
financing  activities  when  the Company was engaged in the delivery of turn-key
management  services  for  the  home  health  industry,  predominately  in south
Louisiana  .  Additionally, other debentures, payables and accrued expenses were
incurred  in  the  Intercontinental  Fuel  transaction  described  earlier.

Continuing  negative  operating  results  produced  a working capital deficit of
$1,480,123  for  the  year  ended  December  31,  2003.  The Company's recurring
negative  financial  results raise substantial doubt about the Company's ability
to  continue  as  a  going  concern.

The  Company  currently  anticipates that its existing cash and cash equivalents
balance  will  fund  operations  and  continue energy development at the current
level  of  activity  into  the  second quarter of 2004. The Company will need to
raise additional funds through additional debt or equity financing. There can be
no  assurance  that  additional  equity or debt financing will be available when
needed  or  on  terms  acceptable  to  the  Company.

The  market  price  of  the  Company's common stock has fluctuated significantly
since  it  began  to  be  publicly  traded in 1998 and may continue to be highly
volatile.  Factors  such  as  the  ability of the Company to achieve development
goals,  ability  of  the  Company  to  profitably  complete energy projects, the
ability  of the Company to raise additional funds, general market conditions and
other  factors  affecting  the  Company's business that are beyond the Company's
control  may cause significant fluctuations in the market price of the Company's
common  stock.  The  market  prices  of  the stock of many energy companies have
fluctuated  substantially,  often  unrelated  to  the  operating or research and
development  performance  of  the  specific  companies. Such market fluctuations
could  adversely  affect  the  market  price  for  the  Company's  common stock.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

The  Company's discussion and analysis of its financial condition and results of
operations are based upon its consolidated financial statements, which have been
prepared  in  accordance  with  generally  accepted accounting principles in the
United  States.  The  preparation  of  these  financial  statements requires the
Company  to  make  estimates  and  judgments that affect the reported amounts of
assets,  liabilities, revenue and expenses, and related disclosure of contingent
assets  and  liabilities.  On  an  ongoing  basis,  the  Company  evaluates  its
estimates.  The  Company  bases  its  estimates  on historical experience and on
various  other  assumptions  that  are  believed  to  be  reasonable  under  the
circumstances.  These  estimates  and  assumptions  provide  a  basis for making
judgments  about  the  carrying  values  of  assets and liabilities that are not
readily  apparent  from  other  sources.  Actual  results  may differ from these
estimates  under  different assumptions or conditions, and these differences may
be  material.

FORWARD-LOOKING INFORMATION - GENERAL
This  report  contains a number of forward-looking statements, which reflect the
Company's  current views with respect to future events and financial performance
including  statements regarding the Company's projections. These forward-looking
statements  are  subject  to  certain  risks  and uncertainties that could cause
actual  results  to  differ  materially  from  historical  results  or  those
anticipated.  In  this  report,  the words "anticipates", "believes", "expects",
"intends",  "future",  "plans",  "targets"  and  similar  expressions  identify
forward-looking statements. Readers are cautioned to not place undue reliance on
the forward-looking statements contained herein, which speak only as of the date
hereof  the  Company  undertakes  no  obligation  to  publicly  revise  these
forward-looking  statements,  to  reflect events or circumstances that may arise
after  the  date  hereof.  Additionally,  these  statements are based on certain
assumptions  that  may  prove  to  be erroneous and are subject to certain risks
including,  but  not  limited  to,  the  Company's  dependence  on  limited cash
resources,  and  its  dependence  on  certain  key personnel within the Company.
Accordingly,  actual  results  may  differ,  possibly  materially,  from  the
predictions  contained  herein.

ITEM 3. CONTROLS AND PROCEDURES.
Timothy  G.  Byrd,  Sr., our Chief Executive Officer and Acting Chief Accounting
Officer,  has  concluded  that  our  disclosure  controls  and  procedures  are
appropriate  and effective. He has evaluated these controls and procedures as of
a  date  within  90 days of the filing date of this report on Form 10-QSB. There
were  no  significant  changes in our internal controls or in other factors that
could  significantly  affect  these  controls  subsequent  to  the date of their
evaluation,  including  any  corrective  actions  with  regard  to  significant
deficiencies  and  material  weaknesses.


<PAGE>
                                     PART II

Pursuant  to  the  Instructions on Part II of the Form 10-QSB, Items 1, 3, and 5
are  omitted.

ITEM 2. CHANGES IN SECURITIES

The  following information sets forth certain information for all securities the
Company  issued  from  January  1,  2004 through March 31, 2004, in transactions
without  registration  under the Act. There were no underwriters in any of these
transactions,  nor  were any sales commissions paid thereon. The securities were
issued  pursuant  to  Section  4(2)  of  the  Act.

100,000  shares  were  issued  for  services  in  the  first  quarter  of  2004.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

None

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

EXHIBIT INDEX

EXHIBIT 31          Certifications

EXHIBIT 32.1        Certification  of  Principal Executive Officer and Principal
                    Financial  Officer  pursuant  to Section 302 of the Sarbanes
                    Oxley  Act  of  2002,  with  respect  to  the  registrant's
                    quarterly  report  on Form 10QSB for the quarter ended March
                    31,  2004
EXHIBIT 32.2        Certification  of  Principal Executive Officer and Principal
                    Financial  Officer  pursuant  to Section 906 Of the Sarbanes
                    Oxley Act of 2002, with respect to the registrants quarterly
                    report  on  Form  10QSB for the quarter ended March 31, 2004

                                   SIGNATURES

Pursuant  to  the requirements of section 13 or 15(d) of the Securities Exchange
Act  of  1934,  the undersigned has duly caused this Form 10-QSB to be signed on
its  behalf by the undersigned, there unto duly authorized, in the City of Baton
Rouge,  Louisiana,  on  May  20,  2004.

CONSOLIDATED MEDICAL MANAGEMENT, INC.


By:  /s/  Timothy  G.  Byrd,  Sr.
    ------------------------
---------------------------------------------
       Timothy  G.  Byrd,  Sr.
       Chief  Executive  Officer,  Acting Chief Accounting Officer, and Director


<PAGE>